相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus Aureus Infections in Adults and Children
Catherine Liu et al.
CLINICAL INFECTIOUS DISEASES (2011)
Clinical outcomes and nephrotoxicity associated with vancomycin trough concentrations during treatment of deep-seated infections
Elizabeth D. Hermsen et al.
EXPERT OPINION ON DRUG SAFETY (2010)
Is High Vancomycin Minimum Inhibitory Concentration a Good Marker to Predict the Outcome of Methicillin-Resistant Staphylococcus aureus Bacteremia?
Antonio Lalueza et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Staphylococcus aureus Panton-Valentine Leukocidin Is a Very Potent Cytotoxic Factor for Human Neutrophils
Bettina Loeffler et al.
PLOS PATHOGENS (2010)
Pharmacodynamics of Vancomycin at Simulated Epithelial Lining Fluid Concentrations against Methicillin-Resistant Staphylococcus aureus (MRSA): Implications for Dosing in MRSA Pneumonia
Yoriko Harigaya et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Paradoxical Relationship between the Clinical Outcome of Staphylococcus aureus Bacteremia and the Minimum Inhibitory Concentration of Vancomycin
James Price et al.
CLINICAL INFECTIOUS DISEASES (2009)
Relationship between Initial Vancomycin Concentration-Time Profile and Nephrotoxicity among Hospitalized Patients
Thomas P. Lodise et al.
CLINICAL INFECTIOUS DISEASES (2009)
Loss of vancomycin bactericidal activity against accessory gene regulator (agr) dysfunctional Staphylococcus aureus under conditions of high bacterial density
Brian T. Tsuji et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2009)
Clinical features and treatment outcomes of vancomycin-intermediate Staphylococcus aureus (VISA) and heteroresistant vancomycin-intermediate Staphylococcus aureus (hVISA) in a tertiary care institution in Singapore
R. K. C. Fong et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2009)
Vancomycin MIC plus Heteroresistance and Outcome of Methicillin-Resistant Staphylococcus aureus Bacteremia: Trends over 11 Years
Adina C. Musta et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2009)
Reduced Susceptibility to Vancomycin Influences Pathogenicity in Staphylococcus aureus Infection
Anton Y. Peleg et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Clinical Features of Heteroresistant Vancomycin-Intermediate Staphylococcus aureus Bacteremia versus Those of Methicillin-Resistant S. aureus Bacteremia
Yasmin Maor et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists
M. Rybak et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2008)
Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin
T. P. Lodise et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia
Alex Soriano et al.
CLINICAL INFECTIOUS DISEASES (2008)
Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains
George Sakoulas et al.
CLINICAL INFECTIOUS DISEASES (2008)
Associations between the genotypes of Staphylococcus aureus bloodstream isolates and clinical characteristics and outcomes of bacteremic patients
Tahaniyat Lalani et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2008)
Community-acquired methicillin-resistant Staphylococcus aureus:: the role of Panton-Valentine Leukocidin
Susan Boyle-Vavra et al.
LABORATORY INVESTIGATION (2007)
Clinical presentation, diagnosis, and quality of life issues in restless legs syndrome
Clete A. Kushida
AMERICAN JOURNAL OF MEDICINE (2007)
High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections -: Efficacy and toxicity
Levita K. Hidayat et al.
ARCHIVES OF INTERNAL MEDICINE (2006)
The pharmacokinetic and pharmacodynamic properties of vancomycin
MJ Rybak
CLINICAL INFECTIOUS DISEASES (2006)
Adaptation of methicillin-resistant Staphylococcus aureus in the face of vancomycin therapy
G Sakoulas et al.
CLINICAL INFECTIOUS DISEASES (2006)
Detection of Panton-Valentine leukocidin gene in Staphylococcus aureus by LightCycler PCR:: clinical and epidemiological aspects
D Johnsson et al.
CLINICAL MICROBIOLOGY AND INFECTION (2004)
Rapid detection of Panton-Valentine leukocidin from clinical isolates of Staphylococcus aureus strains by real-time PCR
RH Deurenberg et al.
FEMS MICROBIOLOGY LETTERS (2004)
Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections
PA Moise-Broder et al.
CLINICAL PHARMACOKINETICS (2004)
Staphylococcus aureus accessory gene regulator (agr) group II:: Is there a relationship to the development of intermediate-level glycopeptide resistance?
G Sakoulas et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: Establishing a national database
LK McDougal et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2003)
Accessory gene regulator (agr) locus in geographically diverse Staphylococcus aureus isolates with reduced susceptibility to vancomycin
G Sakoulas et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
分享论文
